S. 1096
March 24, 2025
Ms. Klobuchar (for herself, Mr. Grassley, Mr. Durbin, Mr. Cramer, Mr. Blumenthal, Ms. Ernst, Mr. Welch, Mr. Kelly, and Mr. Booker) introduced the following bill; which was read twice and referred to the Committee on the Judiciary
A BILL
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Preserve Access to Affordable Generics and Biosimilars Act”.